Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1318691

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1318691

Pharmaceutical Gelatin Market by Source (Bovine Bone, Bovine Skin, Marine), Type (Type A, Type B), Function, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & Online Access - 1 Year (Single User License)
USD 4749
PDF, Excel & Online Access - 1 Year (Up to 5 User License)
USD 5749
PDF, Excel & Online Access - 1 Year (Site License)
USD 6749
PDF, Excel & Online Access - 1 Year (Enterprise User License)
USD 8749

Add to Cart

The Global Pharmaceutical Gelatin Market is forecasted to grow significantly, with a projected USD 1,207.09 million in 2023 at a CAGR of 6.42% and expected to reach a staggering USD 1,869.06 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmaceutical Gelatin Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmaceutical Gelatin Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Source, market is studied across Bovine Bone, Bovine Skin, Marine, Porcine, and Poultry. The Bovine Skin is projected to witness significant market share during forecast period.

Based on Type, market is studied across Type A and Type B. The Type B is projected to witness significant market share during forecast period.

Based on Function, market is studied across Gelling Agents, Stabilizing Agents, and Thickening Agents. The Stabilizing Agents is projected to witness significant market share during forecast period.

Based on Application, market is studied across Absorbable Hemostats, Hard Capsules, Soft Capsules, and Tablets. The Hard Capsules is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmaceutical Gelatin Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Gelatin Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Gelatin Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Gelatin Market?

4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Gelatin Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Gelatin Market?

6. What is the market share of the leading vendors in the Global Pharmaceutical Gelatin Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Gelatin Market?

Product Code: MRR-4F4C3626366A

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pharmaceutical Gelatin Market, by Source, 2022 vs 2030
  • 4.3. Pharmaceutical Gelatin Market, by Type, 2022 vs 2030
  • 4.4. Pharmaceutical Gelatin Market, by Function, 2022 vs 2030
  • 4.5. Pharmaceutical Gelatin Market, by Application, 2022 vs 2030
  • 4.6. Pharmaceutical Gelatin Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Large scale use of gelatin in pharma drug dosage
      • 5.1.1.2. Prevalence of chronic and infectious disorders
      • 5.1.1.3. Increasing clinical trials and preliminary drug studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with Pharmaceutical Gelatin
    • 5.1.3. Opportunities
      • 5.1.3.1. Recent advancements in gelatin nanoparticle in vaccine and drug delivery
      • 5.1.3.2. Improvements in supply chain and distribution network
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and quality concerns with pharmaceutical gelatin
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Pharmaceutical Gelatin Market, by Source

  • 6.1. Introduction
  • 6.2. Bovine Bone
  • 6.3. Bovine Skin
  • 6.4. Marine
  • 6.5. Porcine
  • 6.6. Poultry

7. Pharmaceutical Gelatin Market, by Type

  • 7.1. Introduction
  • 7.2. Type A
  • 7.3. Type B

8. Pharmaceutical Gelatin Market, by Function

  • 8.1. Introduction
  • 8.2. Gelling Agents
  • 8.3. Stabilizing Agents
  • 8.4. Thickening Agents

9. Pharmaceutical Gelatin Market, by Application

  • 9.1. Introduction
  • 9.2. Absorbable Hemostats
  • 9.3. Hard Capsules
  • 9.4. Soft Capsules
  • 9.5. Tablets

10. Americas Pharmaceutical Gelatin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pharmaceutical Gelatin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Gelatin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Product Code: MRR-4F4C3626366A

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL GELATIN MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL GELATIN MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 5. PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 6. PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2022 VS 2030 (%)
  • FIGURE 7. PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. PHARMACEUTICAL GELATIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. PHARMACEUTICAL GELATIN MARKET DYNAMICS
  • FIGURE 10. PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL GELATIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PHARMACEUTICAL GELATIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 5. PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE BONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL GELATIN MARKET SIZE, BY BOVINE SKIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PHARMACEUTICAL GELATIN MARKET SIZE, BY MARINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PHARMACEUTICAL GELATIN MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. PHARMACEUTICAL GELATIN MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE A, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE B, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 14. PHARMACEUTICAL GELATIN MARKET SIZE, BY GELLING AGENTS , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PHARMACEUTICAL GELATIN MARKET SIZE, BY STABILIZING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PHARMACEUTICAL GELATIN MARKET SIZE, BY THICKENING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. PHARMACEUTICAL GELATIN MARKET SIZE, BY ABSORBABLE HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. PHARMACEUTICAL GELATIN MARKET SIZE, BY HARD CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PHARMACEUTICAL GELATIN MARKET SIZE, BY SOFT CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. PHARMACEUTICAL GELATIN MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM PHARMACEUTICAL GELATIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. PHARMACEUTICAL GELATIN MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 191. PHARMACEUTICAL GELATIN MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 192. PHARMACEUTICAL GELATIN MARKET LICENSE & PRICING
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!